Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ypsomed Holding AG's gross profit for the
six
months ended in Mar. 2026 was $208.8 Mil. Ypsomed Holding AG's gross profit for the trailing twelve months (TTM) ended in Mar. 2026 was $397.5 Mil.
Ypsomed Holding AG (OTCPK:YPHDF) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Ypsomed Holding AG had a gross margin of 44.64% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Ypsomed Holding AG Gross Profit Related Terms
Ypsomed Holding AG Gross Profit Historical Data
* Premium members only.
The historical data trend for Ypsomed Holding AG's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG Gross Profit vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Gross Profit distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $397.5 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Ypsomed Holding AG (YPHDF) has a Gross Profit of $397.5 Mil as of Mar. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Ypsomed Holding AG and its competitors.
Is Ypsomed Holding AG's Gross Profit too high?
Ypsomed Holding AG's current Gross Profit is $397.5 Mil. Overall, Ypsomed Holding AG has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Gross Profit compare to ISRG and BDX?
Ypsomed Holding AG's Gross Profit of $397.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Devices & Instruments company?
A good Gross Profit depends on the Medical Devices & Instruments industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Ypsomed Holding AG and its competitors. Ypsomed Holding AG's current Gross Profit is $397.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (YPHDF) is currently considered Fairly Valued. The stock's GF Value™ is $461.36, compared to a current price of $476.49 — trading 3.3% above its estimated fair value. The current Gross Profit is $397.5 Mil. Ypsomed Holding AG's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Ypsomed Holding AG (YPHDF), the current Gross Profit is $397.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (YPHDF) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be overvalued.
The current stock price of $476.49 is trading 3.3% above its estimated GF Value™ of $461.36.
GuruFocus considers Ypsomed Holding AG to be Fairly Valued.
Key valuation signals for YPHDF:
Gross Profit: $397.5 Mil
GF Value™: $461.36 vs. price of $476.49 (3.3% above fair value)
No single metric tells the full story. See the YPHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
94GF Score
Get the complete analysis for YPHDF
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YPHDF has been successfully added to your 
